High-dose chemotherapy and hematopoietic SCT in the management of natural killer-cell malignancies
Open Access
- 21 September 2009
- journal article
- review article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 44 (11), 709-714
- https://doi.org/10.1038/bmt.2009.239
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Phase I study of dexamethasone, methotrexate, ifosfamide, l‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemiaCancer Science, 2008
- Progress in understanding and managing natural killer‐cell malignanciesBritish Journal of Haematology, 2007
- Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasmsBone Marrow Transplantation, 2006
- Midline NK/T-cell lymphoma nasal-type: treatment outcome, the effect ofL-asparaginase based regimen, and prognostic factorsHematological Oncology, 2005
- Selective apoptosis of natural killer‐cell tumours by l‐asparaginaseBritish Journal of Haematology, 2005
- Diagnostic cues for natural killer cell lymphoma: primary nodal presentation and the role of in situ hybridisation for Epstein-Barr virus encoded early small RNA in detecting occult bone marrow involvementJournal of Clinical Pathology, 2005
- Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpointsInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Successful treatment of advanced natural killer cell lymphoma with high-dose chemotherapy and syngeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 1999
- Successful treatment of Epstein–Barr virus-associated natural killer cell large granular lymphocytic leukaemia using allogeneic peripheral blood stem cell transplantationBone Marrow Transplantation, 1998
- CD56+ NK lymphomas:clinicopathological features and prognosisBritish Journal of Haematology, 1997